The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
